Qiagen
QGEN · NYSE
Bulios Fair Price
$32.63
25.3% downside
Trenutna cena
$43.69
Po podatkih Bulios Fair Price je delnica QGEN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Qiagen N.V. (QGEN) is a Dutch company specializing in providing innovative diagnostic tests and technologies in the field of molecular biology. With a broad portfolio of products and services including tests for genetic mutations, infectious disease diagnostics, and analytical tools for genetic material research, Qiagen is one of the leading providers of diagnostic solutions in the market. The company focuses on providing accurate, reliable, and fast diagnostic tests that assist physicians and researchers in identifying and treating diseases. Qiagen also invests in innovation and the development of new diagnostic technologies to continuously improve patient diagnosis and treatment. Qiagen N.V. (QGEN) shares could be suitable for investors looking to invest in biotechnology companies with a focus on molecular diagnostics and innovative research and development in the healthcare sector.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Jon Pratt
Employees
5,500
Headquarters
Venlo
Prihajajoči dogodki
Earnings
Upcoming earnings report